Deutsche Bank’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.93M Buy
373,804
+43,226
+13% +$1.03M ﹤0.01% 1024
2025
Q1
$8.21M Buy
330,578
+96,172
+41% +$2.39M ﹤0.01% 1058
2024
Q4
$4.42M Buy
234,406
+160,094
+215% +$3.02M ﹤0.01% 1382
2024
Q3
$1.12M Sell
74,312
-331,194
-82% -$4.98M ﹤0.01% 2022
2024
Q2
$11.6M Buy
405,506
+95,785
+31% +$2.74M 0.01% 957
2024
Q1
$9.05M Buy
309,721
+1,947
+0.6% +$56.9K ﹤0.01% 1052
2023
Q4
$10.4M Buy
307,774
+125,375
+69% +$4.23M 0.01% 976
2023
Q3
$5.6M Sell
182,399
-51,895
-22% -$1.59M ﹤0.01% 999
2023
Q2
$9.39M Sell
234,294
-11,149
-5% -$447K 0.01% 1006
2023
Q1
$10M Buy
245,443
+9,077
+4% +$370K 0.01% 969
2022
Q4
$9.13M Buy
236,366
+2,606
+1% +$101K 0.01% 990
2022
Q3
$12.4M Buy
233,760
+5,696
+2% +$303K 0.01% 890
2022
Q2
$13.3M Sell
228,064
-15,061
-6% -$878K 0.01% 898
2022
Q1
$18.6M Buy
243,125
+13,114
+6% +$1M 0.01% 857
2021
Q4
$13.8M Sell
230,011
-10,233
-4% -$616K 0.01% 981
2021
Q3
$13.5M Sell
240,244
-34,497
-13% -$1.93M 0.01% 1030
2021
Q2
$16.7M Buy
274,741
+41,241
+18% +$2.5M 0.01% 970
2021
Q1
$16.4M Sell
233,500
-33,026
-12% -$2.31M 0.01% 975
2020
Q4
$15.9M Sell
266,526
-48,401
-15% -$2.9M 0.01% 862
2020
Q3
$18.9M Sell
314,927
-103,840
-25% -$6.24M 0.01% 724
2020
Q2
$22M Sell
418,767
-65,619
-14% -$3.44M 0.02% 667
2020
Q1
$16.2M Sell
484,386
-74,100
-13% -$2.48M 0.01% 722
2019
Q4
$25.3M Buy
558,486
+251,057
+82% +$11.4M 0.02% 700
2019
Q3
$11.7M Sell
307,429
-507,759
-62% -$19.3M 0.01% 1008
2019
Q2
$35.5M Sell
815,188
-19,245
-2% -$837K 0.02% 715
2019
Q1
$31.8M Buy
834,433
+441,398
+112% +$16.8M 0.02% 771
2018
Q4
$16.9M Sell
393,035
-123,855
-24% -$5.33M 0.01% 976
2018
Q3
$25.4M Sell
516,890
-60,057
-10% -$2.95M 0.01% 996
2018
Q2
$18.5M Buy
576,947
+290,428
+101% +$9.31M 0.01% 1233
2018
Q1
$8.92M Sell
286,519
-53,414
-16% -$1.66M ﹤0.01% 1717
2017
Q4
$15.5M Buy
339,933
+27,086
+9% +$1.24M 0.01% 1162
2017
Q3
$11.7M Buy
312,847
+59,235
+23% +$2.22M 0.01% 1340
2017
Q2
$12.1M Buy
253,612
+173,734
+217% +$8.29M 0.01% 1256
2017
Q1
$3.64M Sell
79,878
-380,181
-83% -$17.3M ﹤0.01% 1859
2016
Q4
$14.9M Sell
460,059
-177,592
-28% -$5.74M 0.01% 1023
2016
Q3
$21.8M Buy
637,651
+335,801
+111% +$11.5M 0.02% 875
2016
Q2
$10.2M Buy
301,850
+12,832
+4% +$433K 0.01% 1292
2016
Q1
$15.3M Sell
289,018
-7,214
-2% -$382K 0.01% 1025
2015
Q4
$22.7M Sell
296,232
-97,710
-25% -$7.5M 0.02% 864
2015
Q3
$16.2M Buy
393,942
+82,243
+26% +$3.38M 0.01% 1007
2015
Q2
$22M Sell
311,699
-252,564
-45% -$17.9M 0.01% 882
2015
Q1
$50.1M Buy
564,263
+171,433
+44% +$15.2M 0.03% 537
2014
Q4
$34.8M Sell
392,830
-19,873
-5% -$1.76M 0.02% 728
2014
Q3
$40M Sell
412,703
-46,419
-10% -$4.5M 0.02% 623
2014
Q2
$42.2M Sell
459,122
-68,615
-13% -$6.3M 0.03% 592
2014
Q1
$36.9M Buy
527,737
+8,359
+2% +$585K 0.03% 638
2013
Q4
$29.9M Buy
519,378
+145,946
+39% +$8.39M 0.02% 706
2013
Q3
$18M Buy
373,432
+15,087
+4% +$725K 0.01% 954
2013
Q2
$10.4M Buy
+358,345
New +$10.4M 0.01% 1219